 |
|
|
|
|
|
|
|
|
|
|
|
1 to 14 of 14 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Santana S. et al., 2012, Three more papers supporting the concept of a viral involvement in AD have recently been... 15 Jun 2011.
|
|
|
 |
|
|
Itzhaki R, Wozniak M. on LIVE DISCUSSION: Herpes Simplex and Alzheimer’s—Time to Think Again?, In answer to Terence’s question as to whether AD patients and controls have similar degrees of... 18 Mar 2011.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on NEWS: Toronto: In Small Trial, IVIg Slows Brain Shrinkage, The trial of IVIg (Gammagard) for treating AD patients was done with the aim of augmenting their... 29 Apr 2010.
|
|
|
|
|
|
Dobson C, Itzhaki R, Wozniak M. on PAPER: Soscia SJ. et al., 2010, Comment by Ruth Itzhaki, Curtis Dobson, and Matthew Wozniak
This study provides... 14 Mar 2010.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Clifford DB. et al., 2009, The similarity, or otherwise, of HIV-associated neurologic disease to dementia of the... 4 Jan 2010.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Soscia SJ. et al., 2010, We would like to respond to a few points in the comments by Moir and Tanzi.
They state... 30 Apr 2009.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Soscia SJ. et al., 2010, What good news that microbes are becoming acceptable as possible agents in AD. Regarding the... 8 Apr 2009.
|
|
|
|
|
|
Itzhaki R, Mee A, Wozniak M. on PAPER: Wozniak MA. et al., 2009, We thank the commentators for their (mostly) positive views and hope that our results will... 9 Mar 2009.
|
|
|
|
|
|
Cosby L, Itzhaki R, Wozniak M. on PAPER: Pickford F. et al., 2008, Another Herpes Virus-Alzheimer’s Disease Connection: Beclin Beckons
This study not... 17 Jun 2008.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Buenz EJ. et al., 2006, We would like to add to Brian Balin’s interesting comment that encephalitis and hippocampal... 28 Nov 2006.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Bilbo SD. et al., 2005, Infants and young children are subjected to a battery of infectious agents, including human... 2 Mar 2005.
|
|
|
|
|
|
Itzhaki R, Wozniak M. on PAPER: Hill JM. et al., 2005, Jim Hill and colleagues propose an interesting idea based on our work showing that HSV1 is a... 13 Dec 2004.
|
|
|
|
|
|
Dobson C, Itzhaki R, Wozniak M. on NEWS: Herpes and AD—Virus Hitches Ride with APP, The paper by Satpute-Krishnan et al. links the seemingly disparate worlds of amyloid and... 3 Dec 2003.
|
|
|
|
|
|
Dobson C, Itzhaki R, Wozniak M. on LIVE DISCUSSION: Alzheimer Immunotherapy Trial Grounded: Time to Reassess Safety and Vaccine Design, Ruth Itzhaki, Matthew Wozniak, Curtis Dobson, University of Manchester, UK.
Inflammatory... 26 Feb 2002.
|
|
|
|
|
|
|
1 to 14 of 14 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
